MaxCyte to Participate in William Blair 44th Annual Growth Stock Conference

ROCKVILLE, Md., May 29, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ:MXCT, LSE: MXCT)), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and

GlobeNewswireMay 29 07:05

With 64% Ownership of the Shares, MaxCyte, Inc. (LON:MXCT) Is Heavily Dominated by Institutional Owners

Yahoo FinanceMay 23 06:18

MaxCyte Inc. — Legendary Biotech obtains a non-exclusive global license to use the company's Flow Electroporation technology and expert platform under terms

MaxCyte Inc. — Legendary Biotech obtains a non-exclusive global license to use the company's Flow Electroporation technology and expert platform under terms

Zhitong FinanceMay 22 07:08

MaxCyte Inc - Will Be Eligible for Legendary Biologics' Annual License Fees and Milestones During Clinical Development

MaxCyte Inc - Will Be Eligible for Legendary Biologics' Annual License Fees and Milestones During Clinical Development

Zhitong FinanceMay 22 07:08

MaxCyte Inc - license fees and royalties eligible for net sales of licensed products after successful commercialization

MaxCyte Inc - license fees and royalties eligible for net sales of licensed products after successful commercialization

Zhitong FinanceMay 22 07:08

MaxCyte, Inc. MaxCyte, Inc. -Mxcr-Signs Strategic Platform License

MaxCyte, Inc. MaxCyte, Inc. -Mxcr-Signs Strategic Platform License

Zhitong FinanceMay 22 07:07